Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Return on Assets: 2021-2025

Historic Return on Assets for Janux Therapeutics (JANX) over the last 4 years, with Sep 2025 value amounting to -0.10%.

  • Janux Therapeutics' Return on Assets fell 1.00% to -0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.10%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.10% for FY2024, which is 6.00% up from last year.
  • According to the latest figures from Q3 2025, Janux Therapeutics' Return on Assets is -0.10%, which was up 2.33% from -0.10% recorded in Q2 2025.
  • Over the past 5 years, Janux Therapeutics' Return on Assets peaked at -0.05% during Q3 2021, and registered a low of -0.20% during Q2 2023.
  • Over the past 3 years, Janux Therapeutics' median Return on Assets value was -0.10% (recorded in 2025), while the average stood at -0.12%.
  • As far as peak fluctuations go, Janux Therapeutics' Return on Assets dropped by 11bps in 2022, and later climbed by 13bps in 2024.
  • Over the past 5 years, Janux Therapeutics' Return on Assets (Quarterly) stood at -0.08% in 2021, then declined by 9bps to -0.17% in 2022, then increased by 2bps to -0.15% in 2023, then increased by 7bps to -0.08% in 2024, then fell by 1bps to -0.10% in 2025.
  • Its Return on Assets stands at -0.10% for Q3 2025, versus -0.10% for Q2 2025 and -0.07% for Q1 2025.